SC
Sathisha Cheekanahalli Raju
About Sathisha Cheekanahalli Raju
Data last updated:
Sathisha Cheekanahalli Raju is a Director at Swinnzea Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Swinnzea Pharmaceuticals Private Limited reported revenue of ₹2.73 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Swinnzea Pharmaceuticals Private Limited U24230KA2019PTC122375 | Director | 14 Mar 2019 | 2019 | ₹2.73 Cr (FY 2025) | Active |
Board colleagues of Sathisha Cheekanahalli Raju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jayalakshmi Devanga Srinivas Murthy | 09768896 | Swinnzea Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sathisha Cheekanahalli Raju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sathisha Cheekanahalli Raju
Sathisha Cheekanahalli Raju currently holds 1 directorship: Swinnzea Pharmaceuticals Private Limited (Director, since 14 Mar 2019, revenue ₹2.73 Cr (FY 2025)).
Sathisha Cheekanahalli Raju was first appointed on 14 Mar 2019 as Director at Swinnzea Pharmaceuticals Private Limited.
The current boards of Sathisha Cheekanahalli Raju's companies include Jayalakshmi Devanga Srinivas Murthy (Swinnzea Pharmaceuticals Private Limited).